Fund shareholders of Ultragenyx Pharmaceutical Inc
ISIN US90400D1081 · United States · LEI 529900EV44GVDN1DCX77
- Fund shareholders
- 244
- Of which ETFs
- 50 194 other funds
- Value held
- 587.2M $ 6.7M SEK
- Share of capital
- 27.2 % of 98.6M shares on Jul 31, 2026
244 funds hold this company. This table lists the 243 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| THRIVENT MODERATE ALLOCATION FUND Thrivent Mutual Funds | 1,806 | 44.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| AQR MS Fusion Fund AQR Funds | 1,733 | 36.3K $ | 0.17 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIMT LARGE CAP INDEX FUND SEI INSTITUTIONAL MANAGED TRUST | 1,700 | 35.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Health Care Fund Rydex Series Funds | 1,685 | 35.3K $ | 0.18 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT GLOBAL STOCK FUND Thrivent Mutual Funds | 1,620 | 40K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA Multi-Managed Mid Cap Growth Portfolio SEASONS SERIES TRUST | 1,562 | 32.7K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,562 | 32.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MarketBeta(R) Russell 1000 Growth Equity ETF Goldman Sachs ETF Trust | 1,532 | 35.8K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 1,526 | 32K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AQR CVX Fusion Fund AQR Funds | 1,451 | 30.4K $ | 0.11 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Global Atlantic BlackRock Disciplined Growth Portfolio Forethought Variable Insurance Trust | 1,404 | 29.4K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 1,344 | 28.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT GLOBAL STOCK PORTFOLIO Thrivent Series Fund, Inc. | 1,342 | 28.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Growth Fund VALIC Co I | 1,306 | 30.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| New Covenant Growth Fund NEW COVENANT FUNDS | 1,143 | 23.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 1,058 | 22.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AQR LSE Fusion Fund AQR Funds | 1,038 | 21.7K $ | 0.11 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilmington Large-Cap Strategy Fund Wilmington Funds | 950 | 23.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Health Care Fund Rydex Variable Trust | 882 | 18.5K $ | 0.15 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP JPMorgan Select Mid Cap Value Managed Volatility Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 819 | 17.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Nasdaq Premium Income Active ETF BlackRock ETF Trust | 814 | 17.1K $ | 0.14 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 758 | 15.9K $ | 0.74 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 748 | 17.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| The Institutional U.S. Equity Portfolio HC Capital Trust | 694 | 14.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| MFS Global Alternative Strategy Fund MFS Series Trust XV | 574 | 14.2K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 560 | 11.7K $ | 0.52 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 557 | 11.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 529 | 12.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SIMT Multi-Asset Inflation Managed Fund SEI INSTITUTIONAL MANAGED TRUST | 500 | 10.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Health Innovation Active ETF BlackRock ETF Trust | 460 | 11.4K $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| LargeCap Growth Account I Principal Variable Contract Funds, Inc | 439 | 9.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AMT Diversified Equity Fund ADVISER MANAGED TRUST | 427 | 10.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 400 | 8.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| 1290 Avantis U.S. Large Cap Growth Fund 1290 Funds | 398 | 9.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 396 | 9.8K $ | 0.13 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 353 | 7.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 347 | 8.6K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION FUND Thrivent Mutual Funds | 260 | 6.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 196 | 4.8K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VIP Hedged Equity Portfolio Variable Insurance Products Fund VI | 94 | 2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Enhanced Large Cap Core Active ETF BlackRock ETF Trust | 34 | 839.5 $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Mid Cap ETF Columbia ETF Trust I | 21 | 440 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 7 | 163.7 $ | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Motley Fool Small-Cap Growth ETF RBB Fund, Inc. | 2.82 % | as of Feb 28, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 1.78 % | as of Feb 28, 2026 ↗ |
| AMG Frontier Small Cap Growth Fund AMG Funds I | 1.49 % | as of Apr 30, 2026 ↗ |
| Harbor Human Capital Factor US Small Cap ETF Harbor ETF Trust | 1.31 % | as of Apr 30, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 1.16 % | as of Sep 30, 2025 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 1.09 % | as of Apr 30, 2026 ↗ |
| AMG GW&K Small/Mid Cap Growth Fund AMG Funds IV | 1.03 % | as of Apr 30, 2026 ↗ |
| AMG GW&K Small Cap Growth Fund AMG Funds IV | 1.02 % | as of Apr 30, 2026 ↗ |
| ALGER WEATHERBIE SPECIALIZED GROWTH FUND ALGER FUNDS | 0.92 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.88 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 242 | -1 | 26,776,226 | -16.9 % |
| 2026Q1 | 243 | -58 | 32,236,939 | -11.4 % |
| 2025Q4 | 301 | -20 | 36,389,700 | +10.4 % |
| 2025Q3 | 321 | +29 | 32,953,092 | +4.9 % |
| 2025Q2 | 292 | -6 | 31,414,853 | -0.3 % |
| 2025Q1 | 298 | -1 | 31,519,019 | -8.6 % |
| 2024Q4 | 299 | +9 | 34,468,447 | +3.7 % |
| 2024Q3 | 290 | 0 | 33,240,233 | +4.5 % |
| 2024Q2 | 290 | +16 | 31,800,888 | +0.9 % |
| 2024Q1 | 274 | -3 | 31,522,849 | +0.6 % |
| 2023Q4 | 277 | 31,337,170 |
Institutional managers
287 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 7,299,598 | 152.9M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 5,021,441 | 105.2M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 4,578,024 | 95.9M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 3,648,795 | 76.4M $ | as of Mar 31, 2026 |
| SANDS CAPITAL MANAGEMENT, LLC | 3,214,533 | 67.3M $ | as of Mar 31, 2026 |
| Sofinnova Investments, Inc. | 3,145,888 | 65.9M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 2,640,812 | 55.3M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 2,380,000 | 49.9M $ | as of Mar 31, 2026 |
| Assenagon Asset Management S.A. | 2,257,671 | 47.3M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 2,205,820 | 46.2M $ | as of Mar 31, 2026 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2,191,182 | 45.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 2,115,491 | 44.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,849,391 | 38.8M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,772,184 | 37.1M $ | as of Mar 31, 2026 |
| GW&K Investment Management, LLC | 1,615,426 | 33.8K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,500,528 | 31.4M $ | as of Mar 31, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,431,071 | 30M $ | as of Mar 31, 2026 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,426,834 | 29.9M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,261,018 | 26.4M $ | as of Mar 31, 2026 |
| Rock Springs Capital Management LP | 1,218,773 | 25.5M $ | as of Mar 31, 2026 |
| Jones Hill Capital LP | 1,165,557 | 24.4M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 1,096,182 | 23M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,046,546 | 21.9M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 914,760 | 19.2M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 893,295 | 18.7M $ | as of Mar 31, 2026 |
Declared shareholders of Ultragenyx Pharmaceutical Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Portfolio Management | 5.50 % | 5,410,208 | as of Mar 31, 2026 · SCHEDULE 13G |
| STATE STREET CORPORATION | 5.10 % | 5,021,441 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Ultragenyx Pharmaceutical Inc". https://titelia.com/en/stocks/ultragenyx-pharmaceutical-inc-US90400D1081